Trial | NCT04498676  Report issue

Title

50 Human Subject Repeat Insult Patch Test
50 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Indication/Condition

    Erythema ...

  • Study Participants

    50
Consumer products or raw materials designed for consistent reapplication to areas of the skin may, under proper conditions, prove to be contact sensitizers or irritants in certain individuals. It is the intention of a Repeat Insult Patch Test (RIPT) to provide a basis for evaluation of this irritation/sensitization potential if such exists.
Study Started
Jan 18
2017
Primary Completion
Feb 08
2017
Study Completion
Mar 02
2017
Last Update
Aug 04
2020

Other CB-0002B

CB-0002B (choline geranate) is a viscous transparent colorless to light yellow liquid

Test product Experimental

Criteria 

Inclusion Criteria:

Individuals who are not currently under a doctor's care
Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the Investigator.
Individuals free of any acute or chronic disease that might interfere with or increase the risk of study participation.
Individuals who will complete a preliminary medical history form mandated by AMA Laboratories, Inc. and are in general good health.
Individuals, who will read, understand and sign an informed consent document relating to the specific type of study they are subscribing. Consent forms are kept on file and are available for examination on the premises of AMA Laboratories, Inc. only.
Individuals able to cooperate with the Investigator and research staff, willing to have test materials applied according to the protocol, and complete the full course of the study.

Exclusion Criteria:

Individuals under 18 years of age.
Individuals who are currently under a doctor's care.
Individuals who are currently taking any medication (topical or systemic) that may mask or interfere with the test results.
Subjects with a history of any acute or chronic disease that might interfere with or increase the risk associated with study participation.
Individuals diagnosed with chronic skin allergies.
Female volunteers who indicate that they are pregnant or lactating.
No Results Posted